Authors:
Shamash, J
O'Doherty, CA
Oliver, RTD
Kelsey, S
Gupta, RK
Gallagher, CJ
Newland, AC
Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
Authors:
Mulatero, C
McClaren, BR
Mason, M
Oliver, RTD
Gallagher, CJ
Citation: C. Mulatero et al., Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma, BR J CANC, 83(12), 2000, pp. 1612-1616
Authors:
Shamash, J
Oliver, RTD
Gallagher, CJ
Newland, AC
Lister, TA
Kelsey, S
Gupta, RK
O'Doherty, CA
Citation: J. Shamash et al., Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy, BR J CANC, 82(12), 2000, pp. 2022-2023
Authors:
Shamash, J
Oliver, RTD
Ong, J
Raja, M
Edmonds, P
Gallagher, CJ
Ostrowski, MJ
LeVay, J
Williams, M
Citation: J. Shamash et al., Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy, ANN ONCOL, 10(6), 1999, pp. 685-692
Authors:
Papamichael, D
Seymour, MT
Penson, RT
Wilson, P
Gallagher, CJ
Besser, GM
Slevin, ML
Citation: D. Papamichael et al., Double modulation of 5-fluorouracil with interferon alpha-2a and high-doseleucovorin in advanced neuroendocrine tumours, EUR J CANC, 34(13), 1998, pp. 2133-2134